<!DOCTYPE html><html lang="en" class="server-only"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/><title>Unlocking Precision Medicine: Our Series A in Watchmaker Genomics - Eclipse</title><link rel="canonical" href="index.html"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="article"/><meta property="og:title" content="Unlocking Precision Medicine: Our Series A in Watchmaker Genomics - Eclipse"/><meta property="og:description" content="The Eclipse team is thrilled to participate in Watchmaker Genomics&#x27; $40M Series A to accelerate its mission of enabling applications focused on the reading, writing, and editing of DNA and RNA"/><meta property="og:url" content="https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/"/><meta property="og:site_name" content="Eclipse"/><meta property="article:published_time" content="2022-06-02T15:46:59+00:00"/><meta property="article:modified_time" content="2022-11-03T19:56:11+00:00"/><meta property="og:image" content="https://eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg"/><meta property="og:image:width" content="1280"/><meta property="og:image:height" content="876"/><meta property="og:image:type" content="image/jpeg"/><meta name="author" content="Justin Butler"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:creator" content="@eclipseventures"/><meta name="twitter:site" content="@eclipseventures"/><meta name="twitter:label1" content="Written by"/><meta name="twitter:data1" content="Justin Butler"/><meta name="twitter:label2" content="Est. reading time"/><meta name="twitter:data2" content="4 minutes"/><script type="application/ld+json" class="yoast-schema-graph">{"@context":"https://schema.org","@graph":[{"@type":"WebPage","@id":"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/","url":"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/","name":"Unlocking Precision Medicine: Our Series A in Watchmaker Genomics - Eclipse","isPartOf":{"@id":"https://eclipsevcprod.wpengine.com/#website"},"primaryImageOfPage":{"@id":"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#primaryimage"},"image":{"@id":"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#primaryimage"},"thumbnailUrl":"https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876&ssl=1","datePublished":"2022-06-02T15:46:59+00:00","dateModified":"2022-11-03T19:56:11+00:00","author":{"@id":"https://eclipsevcprod.wpengine.com/#/schema/person/a11b6fbff0284496e1bbe2056e0bf6d5"},"breadcrumb":{"@id":"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#primaryimage","url":"https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876&ssl=1","contentUrl":"https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876&ssl=1","width":1280,"height":876},{"@type":"BreadcrumbList","@id":"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://eclipse.vc/"},{"@type":"ListItem","position":2,"name":"Unlocking Precision Medicine: Our Series A in Watchmaker Genomics"}]},{"@type":"WebSite","@id":"https://eclipsevcprod.wpengine.com/#website","url":"https://eclipsevcprod.wpengine.com/","name":"Eclipse","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://eclipsevcprod.wpengine.com/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https://eclipsevcprod.wpengine.com/#/schema/person/a11b6fbff0284496e1bbe2056e0bf6d5","name":"Justin Butler","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://eclipsevcprod.wpengine.com/#/schema/person/image/","url":"https://secure.gravatar.com/avatar/7bd4dbca88ac7a9e2a5851061b2630fa?s=96&d=mm&r=g","contentUrl":"https://secure.gravatar.com/avatar/7bd4dbca88ac7a9e2a5851061b2630fa?s=96&d=mm&r=g","caption":"Justin Butler"},"url":"https://eclipsevcprod.wpengine.com/blog/author/justin-butler/"}]}</script><meta name="theme-color" content="#ffffff"/><meta name="msapplication-TileColor" content="#ffffff"/><link rel="apple-touch-icon" sizes="180x180" href="../../favicons/apple-touch-icon.png"/><link rel="icon" type="image/png" sizes="32x32" href="../../favicons/favicon-32x32.png"/><link rel="icon" type="image/png" sizes="16x16" href="../../favicons/favicon-16x16.png"/><link rel="manifest" href="../../favicons/site.webmanifest" crossorigin="use-credentials"/><link rel="mask-icon" href="../../favicons/safari-pinned-tab.svg" color="#000000"/><link rel="shortcut icon" href="../../favicons/favicon.ico"/><meta name="msapplication-config" content="/favicons/browserconfig.xml"/><meta name="next-head-count" content="34"/><link rel="preload" href="../../_next/static/css/2a1ae64787bca2b8.css" as="style"/><link rel="stylesheet" href="../../_next/static/css/2a1ae64787bca2b8.css" data-n-g=""/><link rel="preload" href="../../_next/static/css/9e48c417edf57fbb.css" as="style"/><link rel="stylesheet" href="../../_next/static/css/9e48c417edf57fbb.css" data-n-p=""/><link rel="preload" href="../../_next/static/css/99307392305fa1c6.css" as="style"/><link rel="stylesheet" href="../../_next/static/css/99307392305fa1c6.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="../../_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="../../_next/static/chunks/webpack-a083670f4f93d229.js" defer=""></script><script src="../../_next/static/chunks/framework-1b1477f9717fa649.js" defer=""></script><script src="../../_next/static/chunks/main-9df23afce8a37256.js" defer=""></script><script src="../../_next/static/chunks/pages/_app-b6f47eef7b5d62d4.js" defer=""></script><script src="../../_next/static/chunks/421-ab3a214a05e31e83.js" defer=""></script><script src="../../_next/static/chunks/253-9d1b7d0fde0d5c89.js" defer=""></script><script src="../../_next/static/chunks/194-da48473659fed9ed.js" defer=""></script><script src="../../_next/static/chunks/pages/blog/[postSlug]-d13980b33090540f.js" defer=""></script><script src="../../_next/static/PXZ38zmr2SXTuXgWIih-y/_buildManifest.js" defer=""></script><script src="../../_next/static/PXZ38zmr2SXTuXgWIih-y/_ssgManifest.js" defer=""></script></head><script data-cfasync="false">
  if (typeof window !== 'undefined') document.documentElement.classList.add('hide-static-html');
</script><body><noscript id="gtm-noscript"><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-KVCPZSV" height="0" width="0"></iframe></noscript><div id="__next" data-reactroot=""><nav class="Nav_Nav__51Y57"><div class="Nav_overlay__WPxUz"></div><div class="Nav_wrapper__Ov3uU"><div class="Nav_logoCon__xUfYU"><a aria-label="logo-link" href="../../index.html"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 112 70" class="Nav_logo__b6zpd"><path fill="currentColor" d="M37.17 29.26v11.21h7.76v-2.53h-4.77v-8.68h-2.99zm35.24 0h-4.53v11.21h3v-3.22h1.54c2.85 0 4.43-1.68 4.43-4 0-2.32-1.59-3.99-4.44-3.99zm-.15 5.49h-1.39V31.8h1.39a1.48 1.48 0 110 2.95zm19.04-1.06l-1.49-.49c-.54-.18-.79-.4-.79-.83 0-.43.37-.77 1.09-.77a2.52 2.52 0 011.94.81l1.72-1.8A4.79 4.79 0 0090 29.13c-2 0-3.83 1.13-3.83 3.34 0 1.85 1.16 2.84 2.79 3.38l1.32.45c.74.24 1.1.47 1.1 1 0 .63-.53.89-1.42.89a2.83 2.83 0 01-2.34-1.22l-2.22 1.58a5.52 5.52 0 004.6 2.08c3 0 4.26-1.48 4.26-3.54.04-1.58-.72-2.66-2.96-3.4zm20.7-1.91v-2.52h-8.09v11.21H112v-2.53h-5.09v-1.92h4.05v-2.39h-4.05v-1.85H112zM0 40.47h8.09v-2.53H3v-1.92h4.05v-2.39H3v-1.85h5.09v-2.52H0v11.21zm27.48-2.28l-2.19-1.55a3.08 3.08 0 110-3.54l2.19-1.55a5.75 5.75 0 100 6.64zm26.1-11.93h3A34.88 34.88 0 0022.76 0h-1.49a34.89 34.89 0 0132.31 26.26zm.62 3c.298 1.852.448 3.724.45 5.6a35.792 35.792 0 01-.45 5.61h3c.6-3.713.6-7.498 0-11.21h-3zM21.27 69.69h1.49a34.88 34.88 0 0033.79-26.23h-3a34.86 34.86 0 01-32.28 26.23z"></path></svg></a></div><ul class="Nav_routes__RvPpl"><li class="Nav_isDropdown__T7dCf"><div class="Nav_hasChildren__Bx5Kf"><div class="Nav_overlay__WPxUz"></div><button>Our Perspective<span class="Nav_circle__xqUJc"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 25 25" class="Nav_svg__iQzTA"><path stroke="currentColor" stroke-linecap="square" d="M19 11l-6.5 6L6 11"></path></svg></span></button><div class="Nav_childrenItems__ox0Jb"><a aria-label="Mission-menu" class="" href="../../venture-equity/index.html">Mission<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 25 25" class="Nav_svg__iQzTA"><path stroke="currentColor" stroke-linecap="square" d="M19 11l-6.5 6L6 11"></path></svg></a><a aria-label="ECO Report-menu" class="" href="https://ecoreport.eclipse.vc">ECO Report<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 25 25" class="Nav_svg__iQzTA"><path stroke="currentColor" stroke-linecap="square" d="M19 11l-6.5 6L6 11"></path></svg></a></div></div></li><li class=""><a aria-label="Our Team-menu" href="../../team/index.html">Our Team<span class="Nav_bottomLine__KJZ_W"></span></a></li><li class=""><a aria-label="Our Companies-menu" href="../../portfolio/index.html">Our Companies<span class="Nav_bottomLine__KJZ_W"></span></a></li><li class="Nav_isDropdown__T7dCf Nav_activeRoute__irBxx"><div class="Nav_hasChildren__Bx5Kf"><div class="Nav_overlay__WPxUz"></div><button>News &amp; Insights<span class="Nav_circle__xqUJc"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 25 25" class="Nav_svg__iQzTA"><path stroke="currentColor" stroke-linecap="square" d="M19 11l-6.5 6L6 11"></path></svg></span></button><div class="Nav_childrenItems__ox0Jb"><a aria-label="Blog-menu" class="Nav_activeRoute__irBxx" href="../index.html">Blog<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 25 25" class="Nav_svg__iQzTA"><path stroke="currentColor" stroke-linecap="square" d="M19 11l-6.5 6L6 11"></path></svg></a><a aria-label="Recent Press-menu" class="" href="../../press/index.html">Recent Press<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 25 25" class="Nav_svg__iQzTA"><path stroke="currentColor" stroke-linecap="square" d="M19 11l-6.5 6L6 11"></path></svg></a></div></div></li></ul></div></nav><main class="PostComponent_PostComponent__2sBnR"><section class="blog-hero"><div class="BlogHero_BlogHero__WYSP0"><div class="BlogHero_wrapper__zm6cS"><figure class="Image_Image__gOsxL BlogHero_image__A7p8M"><img class="" src="https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876&amp;ssl=1" srcSet="https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876&amp;ssl=1&amp;w=640&amp;quality=90 320w, https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876&amp;ssl=1&amp;w=960&amp;quality=90 480w, https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876&amp;ssl=1&amp;w=1280&amp;quality=90 640w, https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876&amp;ssl=1&amp;w=1600&amp;quality=90 800w" alt="" decoding="async" loading="lazy"/></figure><h2 class="BlogHero_title__zLtPC">Unlocking Precision Medicine: Our Series A in Watchmaker Genomics</h2><div class="BlogHero_data__oHW8v"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 14 15"><path fill="currentColor" d="M13.607 3.186l-1.795-1.795a1.331 1.331 0 00-.948-.393c-.358 0-.695.14-.948.393L.944 10.363a.367.367 0 00-.098.175l-.823 3.455a.81.81 0 00.216.766.81.81 0 00.766.216l3.455-.823a.368.368 0 00.175-.098l8.972-8.972c.254-.253.393-.59.393-.948s-.14-.695-.393-.948zM4.188 13.46l-3.353.799a.076.076 0 01-.074-.021.075.075 0 01-.02-.074l.798-3.354 7.007-7.006 2.649 2.65-7.006 7.006zm8.9-8.9l-1.372 1.372-2.65-2.649 1.372-1.371a.6.6 0 01.853 0l1.796 1.796a.599.599 0 01.177.426.599.599 0 01-.177.427z"></path></svg><p>Justin Butler</p><span class="BlogHero_divider__jOHYB">|</span><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 25 25"><path stroke="currentColor" stroke-width="2" d="M3.08 3.1h18.83v19.26H3.08z"></path><path stroke="currentColor" stroke-linejoin="round" stroke-width="2" d="M7.293 1.042v4.252M17.71 1.042v4.252"></path><path stroke="currentColor" stroke-width="2" d="M2.083 10.608h19.793"></path></svg><p>Jun 2, 2022</p><span class="BlogHero_divider__jOHYB">|</span><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 25 25"><g stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" clip-path="url(#clock_svg__clock_svg__clip0_910_8361)"><path d="M21.917 12.5c0 5.2-4.216 9.416-9.417 9.416a9.417 9.417 0 119.417-9.417z"></path><path d="M11.5 8.291v4.86l3.166 2.515"></path></g><defs><clipPath id="clock_svg__clock_svg__clip0_910_8361"><path fill="#fff" d="M0 0h20.83v20.83H0z" transform="translate(2.083 2.083)"></path></clipPath></defs></svg><p>3<!-- --> MIN</p></div><p class="BlogHero_excerpt___pf74">The Eclipse team is thrilled to participate in Watchmaker Genomics&#8217; $40M Series A to accelerate its mission of enabling applications focused on the reading, writing, and editing of DNA and RNA
</p><div class="SocialShare_SocialShare___TeOc"><p class="SocialShare_text___6CJT">Share</p><span class="SocialShare_separator___IJQy"></span><a aria-label="" target="_blank" rel="no-referrer" href="https://eclipse.vc/blog/[postSlug]/"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso SocialShare_button__SJnz4 ThemedButton_icon__OZyeS">Twitter<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 9 9" class="ThemedButton_svg__7_dpk"><path stroke="currentColor" stroke-linecap="square" stroke-width="0.67" d="M.912 1.088l7.028.043m0 0l.043 7.028M7.94 1.131L.869 8.203"></path></svg></span></a><a aria-label="" target="_blank" rel="no-referrer" href="https://eclipse.vc/blog/[postSlug]/"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso SocialShare_button__SJnz4 ThemedButton_icon__OZyeS">Linkedin<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 9 9" class="ThemedButton_svg__7_dpk"><path stroke="currentColor" stroke-linecap="square" stroke-width="0.67" d="M.912 1.088l7.028.043m0 0l.043 7.028M7.94 1.131L.869 8.203"></path></svg></span></a><a aria-label="" target="_blank" rel="no-referrer" href="mailto:xyz@abc.com?subject=Eclipse VC - &amp;body=Check this website "><span class="ThemedButton ThemedButton_ThemedButton__Hdkso SocialShare_emailAnchor__2HCYL SocialShare_button__SJnz4 ThemedButton_icon__OZyeS">Share by email<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 9 9" class="ThemedButton_svg__7_dpk"><path stroke="currentColor" stroke-linecap="square" stroke-width="0.67" d="M.912 1.088l7.028.043m0 0l.043 7.028M7.94 1.131L.869 8.203"></path></svg></span></a></div></div></div><hr class="Separator_Separator__8u4Nb"/></section><section><div class="FreeForm_FreeForm__IeMdK"><div class="FreeForm_content__1PLNx"><div><p><span>Today, the</span><a href="../../team/index.html"> <span>Eclipse team</span></a><span> is excited to announce our partnership with</span><a href="https://watchmakergenomics.com/"> <span>Watchmaker Genomics</span></a><span> to accelerate its mission of enabling applications focused on the reading, writing, and editing of DNA and RNA to </span><span>facilitate breakthrough scientific research and improve human health.</span><span> We are thrilled to participate in the company’s </span><b>$40M Series A </b><span>in partnership with Decheng Capital.</span></p>
<p><span>Watchmaker is combining the in-depth domain experience of its founders,</span><a href="https://www.linkedin.com/in/trey-foskett-6849936/"> <span>Trey Foskett</span></a><span>,</span><a href="https://www.linkedin.com/in/brian-kudlow-167b8463/"> <span>Brian Kudlow</span></a><span>, and</span><a href="https://www.linkedin.com/in/stephen-picone-a1a86b3/"> <span>Stephen Picone</span></a><span>, in protein engineering with large-scale enzyme manufacturing to address the demanding quality, performance, and scale requirements of high-growth clinical genomics applications. The lack of high-fidelity biological data has hindered the use of genomics in both the lab and clinical settings. A tremendous amount of information is lost in translation between the collection of biological samples and the digital readout of the genomic information they contain, preventing the true promise of genomics from being realized.</span></p>
<p><span>The Watchmaker team is utilizing advanced protein engineering to help gain access to more of that information to enable researchers and clinicians to make better decisions about our care, whether that’s developing new medicines, detecting cancer earlier, or selecting patient-specific treatments. By solving the challenging problem of manipulating and maintaining the integrity of molecular information—DNA and RNA specifically—Watchmaker is helping to expand access to a broader range of sample types, improve assay sensitivity and specificity, and ultimately provide higher quality information necessary to advance truly personalized medicine.&nbsp;</span></p>
<p><span>Watchmaker’s approach to this industry is aligned with Eclipse’s core thesis in a very meaningful way. We broadly focus on GDP-moving industries and the intersection of novel technology to transform these industries. Watchmaker exemplifies this thesis by building the infrastructure to translate new science into products. Their infrastructure integrates computational biology, novel protein engineering technologies, and sophisticated manufacturing capabilities to deliver differentiated genomics solutions in a cost-effective and scalable way.&nbsp;</span></p>
<p><img class="alignnone size-medium wp-image-1346" src="https://i0.wp.com/eclipsevcprod.wpengine.com//wp-content/uploads/2022/06/WMG-13-860x573.jpg?resize=860%2C573&ssl=1" alt width="860" height="573" /></p>
<p><span>When I first connected with Trey, Watchmaker’s Co-Founder and CEO, and learned more about the founding team’s mission and vision, I was impressed, to say the least. Their experience in next-generation sequencing (NGS) and clinical oncology assay development and their track records of building successful life science companies like Kapa Biosystems, Enzymatics, and ArcherDx has uniquely positioned them to build a leading company in the genomics industry.&nbsp;</span></p>
<p><span>There are several defining aspects that set Watchmaker and its approach apart. First, the team builds products with end applications in mind. </span><span>Because of their extensive market expertise, they understand what problems persist and are able to tailor solutions that specifically address these challenges.</span> <span>This is in contrast to other organizations that develop new technologies and then attempt to understand the market need.</span><span> Additionally, by leveraging a mixture of technologies—like next-generation DNA sequencing, computer science, and new manufacturing methods—they’re able to get to the right answer faster and more efficiently than other point solutions on the market. Between the team’s level of expertise, Trey’s vision for the future, and the initial traction the team has achieved—all with zero institutional funding—I truly feel the Watchmaker team has what it takes to build one of the most transformational companies in the space.</span></p>
<p><span>Since the company’s seed round, the team launched its first product in 2020 and has achieved 175% year-over-year revenue growth. With its Series A financing, Watchmaker will accelerate investment in its core-technology platform to deliver a new suite of products that will help address the demands of clinical sequencing and support emerging applications in single-cell analysis, epigenetics, and cell-free DNA. Watchmaker also will expand commercial channels and manufacturing capacity, which will make these product solutions more broadly accessible to the life science and genomics communities.</span></p>
<p><span>Watchmaker is bringing more clarity to the current state of treating many diseases—from diagnosis to new drug development to clinical decisions and treatment—by giving much more information about the genomic information that is governing all the different systems in our bodies. The Eclipse team is excited to work with Watchmaker to unlock information in our biology that will translate to better care and at a cost and scale that can be brought to a broader set of the population.</span></p>
<p><span>Congratulations Trey, Brian, Stephen, and the entire Watchmaker team!</span></p>
<p><a href="https://www.genomeweb.com/business-news/watchmaker-genomics-raises-40m-series-financing#.YpjWg6jMJhE"><em><strong>Read more on today&#8217;s news from GenomeWeb</strong></em></a></p>
<p><b><i>Follow Eclipse Ventures on&nbsp;</i></b><a href="https://www.linkedin.com/company/eclipse-ventures-llc/"><b><i>LinkedIn</i></b></a><b><i>&nbsp;and&nbsp;</i></b><a href="https://twitter.com/EclipseVentures"><b><i>Twitter</i></b></a><b><i> for the latest on the Industrial Evolution</i></b></p>
</div></div></div><div class="PostComponent_wrapper__TWi06"><div class="SocialShare_SocialShare___TeOc"><p class="SocialShare_text___6CJT">Share</p><span class="SocialShare_separator___IJQy"></span><a aria-label="" target="_blank" rel="no-referrer" href="https://eclipse.vc/blog/[postSlug]/"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso SocialShare_button__SJnz4 ThemedButton_icon__OZyeS">Twitter<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 9 9" class="ThemedButton_svg__7_dpk"><path stroke="currentColor" stroke-linecap="square" stroke-width="0.67" d="M.912 1.088l7.028.043m0 0l.043 7.028M7.94 1.131L.869 8.203"></path></svg></span></a><a aria-label="" target="_blank" rel="no-referrer" href="https://eclipse.vc/blog/[postSlug]/"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso SocialShare_button__SJnz4 ThemedButton_icon__OZyeS">Linkedin<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 9 9" class="ThemedButton_svg__7_dpk"><path stroke="currentColor" stroke-linecap="square" stroke-width="0.67" d="M.912 1.088l7.028.043m0 0l.043 7.028M7.94 1.131L.869 8.203"></path></svg></span></a><a aria-label="" target="_blank" rel="no-referrer" href="mailto:xyz@abc.com?subject=Eclipse VC - &amp;body=Check this website "><span class="ThemedButton ThemedButton_ThemedButton__Hdkso SocialShare_emailAnchor__2HCYL SocialShare_button__SJnz4 ThemedButton_icon__OZyeS">Share by email<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 9 9" class="ThemedButton_svg__7_dpk"><path stroke="currentColor" stroke-linecap="square" stroke-width="0.67" d="M.912 1.088l7.028.043m0 0l.043 7.028M7.94 1.131L.869 8.203"></path></svg></span></a></div><div class="Spacer_Spacer__fn2qp" style="--spacer-height:80px" aria-hidden="true"></div><div class="Tags_Tags__SMy5B"><p class="Tags_title__wcq6n">Tags</p><ul><li>Fundraising</li><li>Genomics</li><li>Healthcare</li><li>Infrastructure</li><li>Life Sciences</li><li>Manufacturing</li><li>Series A</li><li>Watchmaker</li></ul></div><div class="Spacer_Spacer__fn2qp" style="--spacer-height:100px" aria-hidden="true"></div></div></section><section><hr class="Separator_Separator__8u4Nb"/><div class="Spacer_Spacer__fn2qp" style="--spacer-height:100px" aria-hidden="true"></div><h3 class="PostComponent_relatedTitle__QdDO2">Related Articles</h3><div class="Spacer_Spacer__fn2qp" style="--spacer-height:100px" aria-hidden="true"></div><div class=""><div class="PostGrid PostGrid_PostGrid__aoT4H PostGrid_count-1__BSFTM"></div></div></section></main><footer class="Footer_Footer__0JIWi"><div class="Footer_wrapper__fRar6 wrapper"><div class="Footer_footerTop__2eyMt"><div class="Footer_companyName__jwFKL company"><div class="Footer_title__o3sfG">Eclipse</div><div class="Footer_eclipse__MnkOJ"></div></div><div class="Footer_newsletterWrapper__2rF4r"><div class="Newsletter_Newsletter__MweEz Newsletter_light__14hIp"><div class="Newsletter_title__YK3ec title">Get the latest news on the Industrial Evolution</div><form class="Newsletter_form__L5fYj"><div class="Newsletter_email__viMdB"><input type="email" placeholder="your@email.com" class="fadeInFrom"/><button class="Newsletter_circle__9XrEQ Newsletter_submit__29xDO fadeInFrom"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 17 17" class="Newsletter_svg__zfXqx"><path stroke="currentColor" stroke-linecap="square" d="M8.591 1L16 8.5m0 0L8.591 16M16 8.5H1"></path></svg></button><span class="Newsletter_underline__89rlp underline"></span></div></form></div></div></div><div class="Footer_footerMiddle__iqB6C extraLink"><div class="Footer_contactInfo__7IDqF"><a aria-label="address-link" target="_blank" class="Footer_address__pzkdv" href="https://goo.gl/maps/ebvadmpmq7AbN2st8">514 High Street<br />
Palo Alto, CA 94301</a><a aria-label="tel-link" class="Footer_phone__XGRgg" href="tel:650-720-4667">650-720-4667</a><a aria-label="email-link" href="mailto:admin@eclipse.vc"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso ThemedButton_action__Jq_He ThemedButton_light__5VNKJ">admin@eclipse.vc</span></a></div><div class="Footer_menuLinks__t10mp"><ul class="Footer_socialLinks__VDbnR"><li><a aria-label="Twitter-menu" target="_blank" rel="no-referrer" href="https://twitter.com/eclipseventures"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso ThemedButton_action__Jq_He ThemedButton_light__5VNKJ">Twitter</span></a></li><li><a aria-label="Linkedin-menu" target="_blank" rel="no-referrer" href="https://www.linkedin.com/company/eclipse-ventures-llc/"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso ThemedButton_action__Jq_He ThemedButton_light__5VNKJ">Linkedin</span></a></li><li><a aria-label="Crunchbase-menu" target="_blank" rel="no-referrer" href="https://www.crunchbase.com/organization/eclipse-ventures"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso ThemedButton_action__Jq_He ThemedButton_light__5VNKJ">Crunchbase</span></a></li></ul><ul class="Footer_externalLinks__UUA3D"><li><a aria-label="LP Portal-menu" target="_blank" rel="no-referrer" href="https://eclipse.arkpes.com/"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso ThemedButton_icon__OZyeS">LP Portal<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 9 9" class="ThemedButton_svg__7_dpk"><path stroke="currentColor" stroke-linecap="square" stroke-width="0.67" d="M.912 1.088l7.028.043m0 0l.043 7.028M7.94 1.131L.869 8.203"></path></svg></span></a></li><li><a aria-label="Portfolio Careers-menu" target="_blank" rel="no-referrer" href="https://jobs.eclipse.vc/"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso ThemedButton_icon__OZyeS">Portfolio Careers<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 9 9" class="ThemedButton_svg__7_dpk"><path stroke="currentColor" stroke-linecap="square" stroke-width="0.67" d="M.912 1.088l7.028.043m0 0l.043 7.028M7.94 1.131L.869 8.203"></path></svg></span></a></li><li><a aria-label="Submit a Business Plan-menu" target="_blank" rel="no-referrer" href="mailto:admin@eclipse.vc"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso ThemedButton_icon__OZyeS">Submit a Business Plan<svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 9 9" class="ThemedButton_svg__7_dpk"><path stroke="currentColor" stroke-linecap="square" stroke-width="0.67" d="M.912 1.088l7.028.043m0 0l.043 7.028M7.94 1.131L.869 8.203"></path></svg></span></a></li></ul></div></div><div class="Footer_footerBottom__iA_rq extraLink"><div class="Footer_left__XgdHt"><div class="Footer_inner__IgH_A"><span>&copy;</span>2024<!-- --> Eclipse</div><button class="Footer_backToTop__it2VF">Back To Top<span class="Footer_circle__P_Fwi"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 25 25" class="Footer_svg__EkLP7"><path stroke="currentColor" stroke-linecap="square" d="M19 11l-6.5 6L6 11"></path></svg></span></button></div><ul class="Footer_links__4bN4O"><li><a aria-label="Privacy policy-menu" href="../../privacy-policy/index.html"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso ThemedButton_action__Jq_He ThemedButton_light__5VNKJ">Privacy policy</span></a></li><li><a aria-label="Terms of service-menu" href="../../terms/index.html"><span class="ThemedButton ThemedButton_ThemedButton__Hdkso ThemedButton_action__Jq_He ThemedButton_light__5VNKJ">Terms of service</span></a></li></ul></div></div></footer><div id="portal"></div></div><script id="__MENUS_DATA__" type="application/json" crossorigin="anonymous">{"acfOptionsFooter":{"footerSettings":{"address":"514 High Street<br />\r\nPalo Alto, CA 94301","newsletterTitle":"Get the latest news on the Industrial Evolution","addressLink":"https://goo.gl/maps/ebvadmpmq7AbN2st8","email":"admin@eclipse.vc","phoneNumber":"650-720-4667","links":[{"url":"/privacy-policy/","label":"Privacy policy"},{"url":"/terms/","label":"Terms of service"}],"externalLinks":[{"fieldGroupName":"external_links","label":"LP Portal","url":"https://eclipse.arkpes.com/"},{"fieldGroupName":"external_links","label":"Portfolio Careers","url":"https://jobs.eclipse.vc/"},{"fieldGroupName":"external_links","label":"Submit a Business Plan","url":"mailto:admin@eclipse.vc"}],"socialMedia":[{"mediaUrl":"https://twitter.com/eclipseventures","mediaLabel":"Twitter"},{"mediaUrl":"https://www.linkedin.com/company/eclipse-ventures-llc/","mediaLabel":"Linkedin"},{"mediaUrl":"https://www.crunchbase.com/organization/eclipse-ventures","mediaLabel":"Crunchbase"}]}},"menuItems":{"nodes":[{"parentId":null,"label":"Our Perspective","path":"/perspective/","childItems":{"nodes":[{"label":"Mission","path":"/perspective/"},{"label":"ECO Report","path":"https://ecoreport.eclipse.vc"}]}},{"parentId":"cG9zdDoxNTgx","label":"Mission","path":"/perspective/","childItems":{"nodes":[]}},{"parentId":"cG9zdDoxNTgx","label":"ECO Report","path":"https://ecoreport.eclipse.vc","childItems":{"nodes":[]}},{"parentId":null,"label":"Our Team","path":"/team/","childItems":{"nodes":[]}},{"parentId":null,"label":"Our Companies","path":"/portfolio/","childItems":{"nodes":[]}},{"parentId":null,"label":"News & Insights","path":"/blog/","childItems":{"nodes":[{"label":"Blog","path":"/blog/"},{"label":"Recent Press","path":"/press/"}]}},{"parentId":"cG9zdDoxMDA4","label":"Blog","path":"/blog/","childItems":{"nodes":[]}},{"parentId":"cG9zdDoxMDA4","label":"Recent Press","path":"/press/","childItems":{"nodes":[]}}]},"allSettings":{"generalSettingsTitle":"Eclipse"}}</script><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"__CLIENT_CACHE_PROP":"{\"cache\":{\"post_18f38_e4afc\":{\"__typename\":\"Post\",\"id\":\"cG9zdDoxMzQ0\",\"date\":\"2022-06-02T15:46:59\",\"title_b28e9_bf21a\":\"Unlocking Precision Medicine: Our Series A in Watchmaker Genomics\",\"uri\":\"/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/\",\"featuredImage\":{\"__typename\":\"NodeWithFeaturedImageToMediaItemConnectionEdge\",\"node\":{\"__typename\":\"MediaItem\",\"id\":\"cG9zdDoyODEw\",\"sourceUrl_772ce_bf21a\":\"https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876\u0026ssl=1\",\"altText\":\"\",\"mediaDetails\":{\"__typename\":\"MediaDetails\",\"width\":1280,\"height\":876}}},\"content_b28e9_bf21a\":\"\u003cp\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eToday, the\u003c/span\u003e\u003ca href=\\\"https://eclipse.vc//team/\\\"\u003e \u003cspan style=\\\"font-weight: 400;\\\"\u003eEclipse team\u003c/span\u003e\u003c/a\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003e is excited to announce our partnership with\u003c/span\u003e\u003ca href=\\\"https://watchmakergenomics.com/\\\"\u003e \u003cspan style=\\\"font-weight: 400;\\\"\u003eWatchmaker Genomics\u003c/span\u003e\u003c/a\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003e to accelerate its mission of enabling applications focused on the reading, writing, and editing of DNA and RNA to \u003c/span\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003efacilitate breakthrough scientific research and improve human health.\u003c/span\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003e We are thrilled to participate in the company’s \u003c/span\u003e\u003cb\u003e$40M Series A \u003c/b\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003ein partnership with Decheng Capital.\u003c/span\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eWatchmaker is combining the in-depth domain experience of its founders,\u003c/span\u003e\u003ca href=\\\"https://www.linkedin.com/in/trey-foskett-6849936/\\\"\u003e \u003cspan style=\\\"font-weight: 400;\\\"\u003eTrey Foskett\u003c/span\u003e\u003c/a\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003e,\u003c/span\u003e\u003ca href=\\\"https://www.linkedin.com/in/brian-kudlow-167b8463/\\\"\u003e \u003cspan style=\\\"font-weight: 400;\\\"\u003eBrian Kudlow\u003c/span\u003e\u003c/a\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003e, and\u003c/span\u003e\u003ca href=\\\"https://www.linkedin.com/in/stephen-picone-a1a86b3/\\\"\u003e \u003cspan style=\\\"font-weight: 400;\\\"\u003eStephen Picone\u003c/span\u003e\u003c/a\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003e, in protein engineering with large-scale enzyme manufacturing to address the demanding quality, performance, and scale requirements of high-growth clinical genomics applications. The lack of high-fidelity biological data has hindered the use of genomics in both the lab and clinical settings. A tremendous amount of information is lost in translation between the collection of biological samples and the digital readout of the genomic information they contain, preventing the true promise of genomics from being realized.\u003c/span\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eThe Watchmaker team is utilizing advanced protein engineering to help gain access to more of that information to enable researchers and clinicians to make better decisions about our care, whether that’s developing new medicines, detecting cancer earlier, or selecting patient-specific treatments. By solving the challenging problem of manipulating and maintaining the integrity of molecular information—DNA and RNA specifically—Watchmaker is helping to expand access to a broader range of sample types, improve assay sensitivity and specificity, and ultimately provide higher quality information necessary to advance truly personalized medicine.\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eWatchmaker’s approach to this industry is aligned with Eclipse’s core thesis in a very meaningful way. We broadly focus on GDP-moving industries and the intersection of novel technology to transform these industries. Watchmaker exemplifies this thesis by building the infrastructure to translate new science into products. Their infrastructure integrates computational biology, novel protein engineering technologies, and sophisticated manufacturing capabilities to deliver differentiated genomics solutions in a cost-effective and scalable way.\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cimg loading=\\\"lazy\\\" decoding=\\\"async\\\" class=\\\"alignnone size-medium wp-image-1346\\\" src=\\\"https://i0.wp.com/eclipsevcprod.wpengine.com//wp-content/uploads/2022/06/WMG-13-860x573.jpg?resize=860%2C573\u0026#038;ssl=1\\\" alt=\\\"\\\" width=\\\"860\\\" height=\\\"573\\\" srcset=\\\"https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/WMG-13.jpg?resize=860%2C573\u0026amp;ssl=1 860w, https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/WMG-13.jpg?resize=768%2C512\u0026amp;ssl=1 768w, https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/WMG-13.jpg?resize=1000%2C667\u0026amp;ssl=1 1000w, https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/WMG-13.jpg?w=1200\u0026amp;ssl=1 1200w\\\" sizes=\\\"(max-width: 860px) 100vw, 860px\\\" data-recalc-dims=\\\"1\\\" /\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eWhen I first connected with Trey, Watchmaker’s Co-Founder and CEO, and learned more about the founding team’s mission and vision, I was impressed, to say the least. Their experience in next-generation sequencing (NGS) and clinical oncology assay development and their track records of building successful life science companies like Kapa Biosystems, Enzymatics, and ArcherDx has uniquely positioned them to build a leading company in the genomics industry.\u0026nbsp;\u003c/span\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eThere are several defining aspects that set Watchmaker and its approach apart. First, the team builds products with end applications in mind. \u003c/span\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eBecause of their extensive market expertise, they understand what problems persist and are able to tailor solutions that specifically address these challenges.\u003c/span\u003e \u003cspan style=\\\"font-weight: 400;\\\"\u003eThis is in contrast to other organizations that develop new technologies and then attempt to understand the market need.\u003c/span\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003e Additionally, by leveraging a mixture of technologies—like next-generation DNA sequencing, computer science, and new manufacturing methods—they’re able to get to the right answer faster and more efficiently than other point solutions on the market. Between the team’s level of expertise, Trey’s vision for the future, and the initial traction the team has achieved—all with zero institutional funding—I truly feel the Watchmaker team has what it takes to build one of the most transformational companies in the space.\u003c/span\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eSince the company’s seed round, the team launched its first product in 2020 and has achieved 175% year-over-year revenue growth. With its Series A financing, Watchmaker will accelerate investment in its core-technology platform to deliver a new suite of products that will help address the demands of clinical sequencing and support emerging applications in single-cell analysis, epigenetics, and cell-free DNA. Watchmaker also will expand commercial channels and manufacturing capacity, which will make these product solutions more broadly accessible to the life science and genomics communities.\u003c/span\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eWatchmaker is bringing more clarity to the current state of treating many diseases—from diagnosis to new drug development to clinical decisions and treatment—by giving much more information about the genomic information that is governing all the different systems in our bodies. The Eclipse team is excited to work with Watchmaker to unlock information in our biology that will translate to better care and at a cost and scale that can be brought to a broader set of the population.\u003c/span\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cspan style=\\\"font-weight: 400;\\\"\u003eCongratulations Trey, Brian, Stephen, and the entire Watchmaker team!\u003c/span\u003e\u003c/p\u003e\\n\u003cp\u003e\u003ca href=\\\"https://www.genomeweb.com/business-news/watchmaker-genomics-raises-40m-series-financing#.YpjWg6jMJhE\\\"\u003e\u003cem\u003e\u003cstrong\u003eRead more on today\u0026#8217;s news from GenomeWeb\u003c/strong\u003e\u003c/em\u003e\u003c/a\u003e\u003c/p\u003e\\n\u003cp\u003e\u003cb\u003e\u003ci\u003eFollow Eclipse Ventures on\u0026nbsp;\u003c/i\u003e\u003c/b\u003e\u003ca href=\\\"https://www.linkedin.com/company/eclipse-ventures-llc/\\\"\u003e\u003cb\u003e\u003ci\u003eLinkedIn\u003c/i\u003e\u003c/b\u003e\u003c/a\u003e\u003cb\u003e\u003ci\u003e\u0026nbsp;and\u0026nbsp;\u003c/i\u003e\u003c/b\u003e\u003ca href=\\\"https://twitter.com/EclipseVentures\\\"\u003e\u003cb\u003e\u003ci\u003eTwitter\u003c/i\u003e\u003c/b\u003e\u003c/a\u003e\u003cb\u003e\u003ci\u003e for the latest on the Industrial Evolution\u003c/i\u003e\u003c/b\u003e\u003c/p\u003e\\n\",\"categories_3cd3e_bf21a\":{\"__typename\":\"PostToCategoryConnection\",\"nodes\":[{\"__typename\":\"Category\",\"id\":\"dGVybToxNjg=\",\"name\":\"Portfolio\",\"databaseId\":168,\"slug\":\"portfolio\",\"count\":41}]},\"seo\":{\"__typename\":\"PostTypeSEO\",\"title\":\"Unlocking Precision Medicine: Our Series A in Watchmaker Genomics - Eclipse\",\"fullHead\":\"\u003c!-- This site is optimized with the Yoast SEO plugin v19.9 - https://yoast.com/wordpress/plugins/seo/ --\u003e\\n\u003clink rel=\\\"canonical\\\" href=\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/\\\" /\u003e\\n\u003cmeta property=\\\"og:locale\\\" content=\\\"en_US\\\" /\u003e\\n\u003cmeta property=\\\"og:type\\\" content=\\\"article\\\" /\u003e\\n\u003cmeta property=\\\"og:title\\\" content=\\\"Unlocking Precision Medicine: Our Series A in Watchmaker Genomics - Eclipse\\\" /\u003e\\n\u003cmeta property=\\\"og:description\\\" content=\\\"The Eclipse team is thrilled to participate in Watchmaker Genomics\u0026#039; $40M Series A to accelerate its mission of enabling applications focused on the reading, writing, and editing of DNA and RNA\\\" /\u003e\\n\u003cmeta property=\\\"og:url\\\" content=\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/\\\" /\u003e\\n\u003cmeta property=\\\"og:site_name\\\" content=\\\"Eclipse\\\" /\u003e\\n\u003cmeta property=\\\"article:published_time\\\" content=\\\"2022-06-02T15:46:59+00:00\\\" /\u003e\\n\u003cmeta property=\\\"article:modified_time\\\" content=\\\"2022-11-03T19:56:11+00:00\\\" /\u003e\\n\u003cmeta property=\\\"og:image\\\" content=\\\"https://eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg\\\" /\u003e\\n\\t\u003cmeta property=\\\"og:image:width\\\" content=\\\"1280\\\" /\u003e\\n\\t\u003cmeta property=\\\"og:image:height\\\" content=\\\"876\\\" /\u003e\\n\\t\u003cmeta property=\\\"og:image:type\\\" content=\\\"image/jpeg\\\" /\u003e\\n\u003cmeta name=\\\"author\\\" content=\\\"Justin Butler\\\" /\u003e\\n\u003cmeta name=\\\"twitter:card\\\" content=\\\"summary_large_image\\\" /\u003e\\n\u003cmeta name=\\\"twitter:creator\\\" content=\\\"@eclipseventures\\\" /\u003e\\n\u003cmeta name=\\\"twitter:site\\\" content=\\\"@eclipseventures\\\" /\u003e\\n\u003cmeta name=\\\"twitter:label1\\\" content=\\\"Written by\\\" /\u003e\\n\\t\u003cmeta name=\\\"twitter:data1\\\" content=\\\"Justin Butler\\\" /\u003e\\n\\t\u003cmeta name=\\\"twitter:label2\\\" content=\\\"Est. reading time\\\" /\u003e\\n\\t\u003cmeta name=\\\"twitter:data2\\\" content=\\\"4 minutes\\\" /\u003e\\n\u003cscript type=\\\"application/ld+json\\\" class=\\\"yoast-schema-graph\\\"\u003e{\\\"@context\\\":\\\"https://schema.org\\\",\\\"@graph\\\":[{\\\"@type\\\":\\\"WebPage\\\",\\\"@id\\\":\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/\\\",\\\"url\\\":\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/\\\",\\\"name\\\":\\\"Unlocking Precision Medicine: Our Series A in Watchmaker Genomics - Eclipse\\\",\\\"isPartOf\\\":{\\\"@id\\\":\\\"https://eclipsevcprod.wpengine.com/#website\\\"},\\\"primaryImageOfPage\\\":{\\\"@id\\\":\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#primaryimage\\\"},\\\"image\\\":{\\\"@id\\\":\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#primaryimage\\\"},\\\"thumbnailUrl\\\":\\\"https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876\u0026ssl=1\\\",\\\"datePublished\\\":\\\"2022-06-02T15:46:59+00:00\\\",\\\"dateModified\\\":\\\"2022-11-03T19:56:11+00:00\\\",\\\"author\\\":{\\\"@id\\\":\\\"https://eclipsevcprod.wpengine.com/#/schema/person/a11b6fbff0284496e1bbe2056e0bf6d5\\\"},\\\"breadcrumb\\\":{\\\"@id\\\":\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#breadcrumb\\\"},\\\"inLanguage\\\":\\\"en-US\\\",\\\"potentialAction\\\":[{\\\"@type\\\":\\\"ReadAction\\\",\\\"target\\\":[\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/\\\"]}]},{\\\"@type\\\":\\\"ImageObject\\\",\\\"inLanguage\\\":\\\"en-US\\\",\\\"@id\\\":\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#primaryimage\\\",\\\"url\\\":\\\"https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876\u0026ssl=1\\\",\\\"contentUrl\\\":\\\"https://i0.wp.com/eclipsevcprod.wpengine.com/wp-content/uploads/2022/06/Unlocking-Precision-Medicine-Our-Series-A-in-Watchmaker-Genomics-1.jpg?fit=1280%2C876\u0026ssl=1\\\",\\\"width\\\":1280,\\\"height\\\":876},{\\\"@type\\\":\\\"BreadcrumbList\\\",\\\"@id\\\":\\\"https://eclipse.vc/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/#breadcrumb\\\",\\\"itemListElement\\\":[{\\\"@type\\\":\\\"ListItem\\\",\\\"position\\\":1,\\\"name\\\":\\\"Home\\\",\\\"item\\\":\\\"https://eclipse.vc/\\\"},{\\\"@type\\\":\\\"ListItem\\\",\\\"position\\\":2,\\\"name\\\":\\\"Unlocking Precision Medicine: Our Series A in Watchmaker Genomics\\\"}]},{\\\"@type\\\":\\\"WebSite\\\",\\\"@id\\\":\\\"https://eclipsevcprod.wpengine.com/#website\\\",\\\"url\\\":\\\"https://eclipsevcprod.wpengine.com/\\\",\\\"name\\\":\\\"Eclipse\\\",\\\"description\\\":\\\"Just another WordPress site\\\",\\\"potentialAction\\\":[{\\\"@type\\\":\\\"SearchAction\\\",\\\"target\\\":{\\\"@type\\\":\\\"EntryPoint\\\",\\\"urlTemplate\\\":\\\"https://eclipsevcprod.wpengine.com/?s={search_term_string}\\\"},\\\"query-input\\\":\\\"required name=search_term_string\\\"}],\\\"inLanguage\\\":\\\"en-US\\\"},{\\\"@type\\\":\\\"Person\\\",\\\"@id\\\":\\\"https://eclipsevcprod.wpengine.com/#/schema/person/a11b6fbff0284496e1bbe2056e0bf6d5\\\",\\\"name\\\":\\\"Justin Butler\\\",\\\"image\\\":{\\\"@type\\\":\\\"ImageObject\\\",\\\"inLanguage\\\":\\\"en-US\\\",\\\"@id\\\":\\\"https://eclipsevcprod.wpengine.com/#/schema/person/image/\\\",\\\"url\\\":\\\"https://secure.gravatar.com/avatar/7bd4dbca88ac7a9e2a5851061b2630fa?s=96\u0026d=mm\u0026r=g\\\",\\\"contentUrl\\\":\\\"https://secure.gravatar.com/avatar/7bd4dbca88ac7a9e2a5851061b2630fa?s=96\u0026d=mm\u0026r=g\\\",\\\"caption\\\":\\\"Justin Butler\\\"},\\\"url\\\":\\\"https://eclipsevcprod.wpengine.com/blog/author/justin-butler/\\\"}]}\u003c/script\u003e\\n\u003c!-- / Yoast SEO plugin. --\u003e\"},\"blocksJSON\":\"[{\\\"innerBlocks\\\":[],\\\"name\\\":\\\"core\\\\/freeform\\\",\\\"postId\\\":1344,\\\"blockType\\\":{\\\"name\\\":\\\"core\\\\/freeform\\\",\\\"keywords\\\":[],\\\"attributes\\\":{\\\"content\\\":{\\\"type\\\":\\\"string\\\",\\\"source\\\":\\\"raw\\\"},\\\"lock\\\":{\\\"type\\\":\\\"object\\\"},\\\"metadata\\\":{\\\"type\\\":\\\"object\\\"}},\\\"providesContext\\\":[],\\\"usesContext\\\":[],\\\"selectors\\\":[],\\\"supports\\\":{\\\"className\\\":false,\\\"customClassName\\\":false,\\\"reusable\\\":false},\\\"styles\\\":[],\\\"variations\\\":[],\\\"blockHooks\\\":[],\\\"apiVersion\\\":3,\\\"title\\\":\\\"Classic\\\",\\\"description\\\":\\\"Use the classic WordPress editor.\\\",\\\"category\\\":\\\"text\\\"},\\\"originalContent\\\":\\\"\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eToday, the\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/eclipsevcprod.wpengine.com\\\\/\\\\/team\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eEclipse team\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e is excited to announce our partnership with\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/watchmakergenomics.com\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWatchmaker Genomics\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e to accelerate its mission of enabling applications focused on the reading, writing, and editing of DNA and RNA to \u003c\\\\/span\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003efacilitate breakthrough scientific research and improve human health.\u003c\\\\/span\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e We are thrilled to participate in the company\\\\u2019s \u003c\\\\/span\u003e\u003cb\u003e$40M Series A \u003c\\\\/b\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003ein partnership with Decheng Capital.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWatchmaker is combining the in-depth domain experience of its founders,\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/www.linkedin.com\\\\/in\\\\/trey-foskett-6849936\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eTrey Foskett\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e,\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/www.linkedin.com\\\\/in\\\\/brian-kudlow-167b8463\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eBrian Kudlow\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e, and\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/www.linkedin.com\\\\/in\\\\/stephen-picone-a1a86b3\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eStephen Picone\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e, in protein engineering with large-scale enzyme manufacturing to address the demanding quality, performance, and scale requirements of high-growth clinical genomics applications. The lack of high-fidelity biological data has hindered the use of genomics in both the lab and clinical settings. A tremendous amount of information is lost in translation between the collection of biological samples and the digital readout of the genomic information they contain, preventing the true promise of genomics from being realized.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eThe Watchmaker team is utilizing advanced protein engineering to help gain access to more of that information to enable researchers and clinicians to make better decisions about our care, whether that\\\\u2019s developing new medicines, detecting cancer earlier, or selecting patient-specific treatments. By solving the challenging problem of manipulating and maintaining the integrity of molecular information\\\\u2014DNA and RNA specifically\\\\u2014Watchmaker is helping to expand access to a broader range of sample types, improve assay sensitivity and specificity, and ultimately provide higher quality information necessary to advance truly personalized medicine.\u0026nbsp;\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWatchmaker\\\\u2019s approach to this industry is aligned with Eclipse\\\\u2019s core thesis in a very meaningful way. We broadly focus on GDP-moving industries and the intersection of novel technology to transform these industries. Watchmaker exemplifies this thesis by building the infrastructure to translate new science into products. Their infrastructure integrates computational biology, novel protein engineering technologies, and sophisticated manufacturing capabilities to deliver differentiated genomics solutions in a cost-effective and scalable way.\u0026nbsp;\u003c\\\\/span\u003e\\\\n\\\\n\u003cimg class=\\\\\\\"alignnone size-medium wp-image-1346\\\\\\\" src=\\\\\\\"https:\\\\/\\\\/eclipsevcprod.wpengine.com\\\\/\\\\/wp-content\\\\/uploads\\\\/2022\\\\/06\\\\/WMG-13-860x573.jpg\\\\\\\" alt=\\\\\\\"\\\\\\\" width=\\\\\\\"860\\\\\\\" height=\\\\\\\"573\\\\\\\"\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWhen I first connected with Trey, Watchmaker\\\\u2019s Co-Founder and CEO, and learned more about the founding team\\\\u2019s mission and vision, I was impressed, to say the least. Their experience in next-generation sequencing (NGS) and clinical oncology assay development and their track records of building successful life science companies like Kapa Biosystems, Enzymatics, and ArcherDx has uniquely positioned them to build a leading company in the genomics industry.\u0026nbsp;\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eThere are several defining aspects that set Watchmaker and its approach apart. First, the team builds products with end applications in mind. \u003c\\\\/span\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eBecause of their extensive market expertise, they understand what problems persist and are able to tailor solutions that specifically address these challenges.\u003c\\\\/span\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eThis is in contrast to other organizations that develop new technologies and then attempt to understand the market need.\u003c\\\\/span\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e Additionally, by leveraging a mixture of technologies\\\\u2014like next-generation DNA sequencing, computer science, and new manufacturing methods\\\\u2014they\\\\u2019re able to get to the right answer faster and more efficiently than other point solutions on the market. Between the team\\\\u2019s level of expertise, Trey\\\\u2019s vision for the future, and the initial traction the team has achieved\\\\u2014all with zero institutional funding\\\\u2014I truly feel the Watchmaker team has what it takes to build one of the most transformational companies in the space.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eSince the company\\\\u2019s seed round, the team launched its first product in 2020 and has achieved 175% year-over-year revenue growth. With its Series A financing, Watchmaker will accelerate investment in its core-technology platform to deliver a new suite of products that will help address the demands of clinical sequencing and support emerging applications in single-cell analysis, epigenetics, and cell-free DNA. Watchmaker also will expand commercial channels and manufacturing capacity, which will make these product solutions more broadly accessible to the life science and genomics communities.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWatchmaker is bringing more clarity to the current state of treating many diseases\\\\u2014from diagnosis to new drug development to clinical decisions and treatment\\\\u2014by giving much more information about the genomic information that is governing all the different systems in our bodies. The Eclipse team is excited to work with Watchmaker to unlock information in our biology that will translate to better care and at a cost and scale that can be brought to a broader set of the population.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eCongratulations Trey, Brian, Stephen, and the entire Watchmaker team!\u003c\\\\/span\u003e\\\\n\\\\n\u003ca href=\\\\\\\"https:\\\\/\\\\/www.genomeweb.com\\\\/business-news\\\\/watchmaker-genomics-raises-40m-series-financing#.YpjWg6jMJhE\\\\\\\"\u003e\u003cem\u003e\u003cstrong\u003eRead more on today's news from GenomeWeb\u003c\\\\/strong\u003e\u003c\\\\/em\u003e\u003c\\\\/a\u003e\\\\n\\\\n\u003cb\u003e\u003ci\u003eFollow Eclipse Ventures on\u0026nbsp;\u003c\\\\/i\u003e\u003c\\\\/b\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/www.linkedin.com\\\\/company\\\\/eclipse-ventures-llc\\\\/\\\\\\\"\u003e\u003cb\u003e\u003ci\u003eLinkedIn\u003c\\\\/i\u003e\u003c\\\\/b\u003e\u003c\\\\/a\u003e\u003cb\u003e\u003ci\u003e\u0026nbsp;and\u0026nbsp;\u003c\\\\/i\u003e\u003c\\\\/b\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/twitter.com\\\\/EclipseVentures\\\\\\\"\u003e\u003cb\u003e\u003ci\u003eTwitter\u003c\\\\/i\u003e\u003c\\\\/b\u003e\u003c\\\\/a\u003e\u003cb\u003e\u003ci\u003e for the latest on the Industrial Evolution\u003c\\\\/i\u003e\u003c\\\\/b\u003e\\\",\\\"saveContent\\\":\\\"\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eToday, the\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/eclipsevcprod.wpengine.com\\\\/\\\\/team\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eEclipse team\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e is excited to announce our partnership with\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/watchmakergenomics.com\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWatchmaker Genomics\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e to accelerate its mission of enabling applications focused on the reading, writing, and editing of DNA and RNA to \u003c\\\\/span\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003efacilitate breakthrough scientific research and improve human health.\u003c\\\\/span\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e We are thrilled to participate in the company\\\\u2019s \u003c\\\\/span\u003e\u003cb\u003e$40M Series A \u003c\\\\/b\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003ein partnership with Decheng Capital.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWatchmaker is combining the in-depth domain experience of its founders,\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/www.linkedin.com\\\\/in\\\\/trey-foskett-6849936\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eTrey Foskett\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e,\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/www.linkedin.com\\\\/in\\\\/brian-kudlow-167b8463\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eBrian Kudlow\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e, and\u003c\\\\/span\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/www.linkedin.com\\\\/in\\\\/stephen-picone-a1a86b3\\\\/\\\\\\\"\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eStephen Picone\u003c\\\\/span\u003e\u003c\\\\/a\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e, in protein engineering with large-scale enzyme manufacturing to address the demanding quality, performance, and scale requirements of high-growth clinical genomics applications. The lack of high-fidelity biological data has hindered the use of genomics in both the lab and clinical settings. A tremendous amount of information is lost in translation between the collection of biological samples and the digital readout of the genomic information they contain, preventing the true promise of genomics from being realized.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eThe Watchmaker team is utilizing advanced protein engineering to help gain access to more of that information to enable researchers and clinicians to make better decisions about our care, whether that\\\\u2019s developing new medicines, detecting cancer earlier, or selecting patient-specific treatments. By solving the challenging problem of manipulating and maintaining the integrity of molecular information\\\\u2014DNA and RNA specifically\\\\u2014Watchmaker is helping to expand access to a broader range of sample types, improve assay sensitivity and specificity, and ultimately provide higher quality information necessary to advance truly personalized medicine.\u0026nbsp;\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWatchmaker\\\\u2019s approach to this industry is aligned with Eclipse\\\\u2019s core thesis in a very meaningful way. We broadly focus on GDP-moving industries and the intersection of novel technology to transform these industries. Watchmaker exemplifies this thesis by building the infrastructure to translate new science into products. Their infrastructure integrates computational biology, novel protein engineering technologies, and sophisticated manufacturing capabilities to deliver differentiated genomics solutions in a cost-effective and scalable way.\u0026nbsp;\u003c\\\\/span\u003e\\\\n\\\\n\u003cimg class=\\\\\\\"alignnone size-medium wp-image-1346\\\\\\\" src=\\\\\\\"https:\\\\/\\\\/eclipsevcprod.wpengine.com\\\\/\\\\/wp-content\\\\/uploads\\\\/2022\\\\/06\\\\/WMG-13-860x573.jpg\\\\\\\" alt=\\\\\\\"\\\\\\\" width=\\\\\\\"860\\\\\\\" height=\\\\\\\"573\\\\\\\"\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWhen I first connected with Trey, Watchmaker\\\\u2019s Co-Founder and CEO, and learned more about the founding team\\\\u2019s mission and vision, I was impressed, to say the least. Their experience in next-generation sequencing (NGS) and clinical oncology assay development and their track records of building successful life science companies like Kapa Biosystems, Enzymatics, and ArcherDx has uniquely positioned them to build a leading company in the genomics industry.\u0026nbsp;\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eThere are several defining aspects that set Watchmaker and its approach apart. First, the team builds products with end applications in mind. \u003c\\\\/span\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eBecause of their extensive market expertise, they understand what problems persist and are able to tailor solutions that specifically address these challenges.\u003c\\\\/span\u003e \u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eThis is in contrast to other organizations that develop new technologies and then attempt to understand the market need.\u003c\\\\/span\u003e\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003e Additionally, by leveraging a mixture of technologies\\\\u2014like next-generation DNA sequencing, computer science, and new manufacturing methods\\\\u2014they\\\\u2019re able to get to the right answer faster and more efficiently than other point solutions on the market. Between the team\\\\u2019s level of expertise, Trey\\\\u2019s vision for the future, and the initial traction the team has achieved\\\\u2014all with zero institutional funding\\\\u2014I truly feel the Watchmaker team has what it takes to build one of the most transformational companies in the space.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eSince the company\\\\u2019s seed round, the team launched its first product in 2020 and has achieved 175% year-over-year revenue growth. With its Series A financing, Watchmaker will accelerate investment in its core-technology platform to deliver a new suite of products that will help address the demands of clinical sequencing and support emerging applications in single-cell analysis, epigenetics, and cell-free DNA. Watchmaker also will expand commercial channels and manufacturing capacity, which will make these product solutions more broadly accessible to the life science and genomics communities.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eWatchmaker is bringing more clarity to the current state of treating many diseases\\\\u2014from diagnosis to new drug development to clinical decisions and treatment\\\\u2014by giving much more information about the genomic information that is governing all the different systems in our bodies. The Eclipse team is excited to work with Watchmaker to unlock information in our biology that will translate to better care and at a cost and scale that can be brought to a broader set of the population.\u003c\\\\/span\u003e\\\\n\\\\n\u003cspan style=\\\\\\\"font-weight: 400;\\\\\\\"\u003eCongratulations Trey, Brian, Stephen, and the entire Watchmaker team!\u003c\\\\/span\u003e\\\\n\\\\n\u003ca href=\\\\\\\"https:\\\\/\\\\/www.genomeweb.com\\\\/business-news\\\\/watchmaker-genomics-raises-40m-series-financing#.YpjWg6jMJhE\\\\\\\"\u003e\u003cem\u003e\u003cstrong\u003eRead more on today's news from GenomeWeb\u003c\\\\/strong\u003e\u003c\\\\/em\u003e\u003c\\\\/a\u003e\\\\n\\\\n\u003cb\u003e\u003ci\u003eFollow Eclipse Ventures on\u0026nbsp;\u003c\\\\/i\u003e\u003c\\\\/b\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/www.linkedin.com\\\\/company\\\\/eclipse-ventures-llc\\\\/\\\\\\\"\u003e\u003cb\u003e\u003ci\u003eLinkedIn\u003c\\\\/i\u003e\u003c\\\\/b\u003e\u003c\\\\/a\u003e\u003cb\u003e\u003ci\u003e\u0026nbsp;and\u0026nbsp;\u003c\\\\/i\u003e\u003c\\\\/b\u003e\u003ca href=\\\\\\\"https:\\\\/\\\\/twitter.com\\\\/EclipseVentures\\\\\\\"\u003e\u003cb\u003e\u003ci\u003eTwitter\u003c\\\\/i\u003e\u003c\\\\/b\u003e\u003c\\\\/a\u003e\u003cb\u003e\u003ci\u003e for the latest on the Industrial Evolution\u003c\\\\/i\u003e\u003c\\\\/b\u003e\\\",\\\"order\\\":0,\\\"get_parent\\\":{},\\\"attributes\\\":[],\\\"attributesType\\\":{\\\"content\\\":{\\\"type\\\":\\\"string\\\",\\\"source\\\":\\\"raw\\\"},\\\"lock\\\":{\\\"type\\\":\\\"object\\\"},\\\"metadata\\\":{\\\"type\\\":\\\"object\\\"}},\\\"dynamicContent\\\":null}]\",\"author\":{\"__typename\":\"NodeWithAuthorToUserConnectionEdge\",\"node\":{\"__typename\":\"User\",\"id\":\"dXNlcjo3Mw==\",\"name\":\"Justin Butler\"}},\"link\":\"https://eclipsevcprod.wpengine.com/blog/unlocking-precision-medicine-our-series-a-in-watchmaker-genomics/\",\"tags_67cce_bf21a\":{\"__typename\":\"PostToTagConnection\",\"nodes\":[{\"__typename\":\"Tag\",\"id\":\"dGVybToyMw==\",\"name\":\"Fundraising\"},{\"__typename\":\"Tag\",\"id\":\"dGVybToxMzg=\",\"name\":\"Genomics\"},{\"__typename\":\"Tag\",\"id\":\"dGVybTo2Ng==\",\"name\":\"Healthcare\"},{\"__typename\":\"Tag\",\"id\":\"dGVybToyNQ==\",\"name\":\"Infrastructure\"},{\"__typename\":\"Tag\",\"id\":\"dGVybToxMzc=\",\"name\":\"Life Sciences\"},{\"__typename\":\"Tag\",\"id\":\"dGVybTozNA==\",\"name\":\"Manufacturing\"},{\"__typename\":\"Tag\",\"id\":\"dGVybToxMzY=\",\"name\":\"Series A\"},{\"__typename\":\"Tag\",\"id\":\"dGVybToxMzU=\",\"name\":\"Watchmaker\"}]},\"excerpt_b28e9_bf21a\":\"\u003cp\u003eThe Eclipse team is thrilled to participate in Watchmaker Genomics\u0026#8217; $40M Series A to accelerate its mission of enabling applications focused on the reading, writing, and editing of DNA and RNA\u003c/p\u003e\\n\"},\"posts_f30bc_3a22e\":{\"__typename\":\"RootQueryToPostConnection\",\"nodes\":[]}}}","__AUTH_CLIENT_CACHE_PROP":"{}"},"__N_SSG":true},"page":"/blog/[postSlug]","query":{"postSlug":"unlocking-precision-medicine-our-series-a-in-watchmaker-genomics"},"buildId":"PXZ38zmr2SXTuXgWIih-y","isFallback":false,"gsp":true,"scriptLoader":[{"id":"gtm-script","strategy":"afterInteractive","dangerouslySetInnerHTML":{"__html":"(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':\nnew Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],\nj=d.createElement(s),dl=l!='dataLayer'?'\u0026l='+l:'';j.async=true;j.src=\n'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);\n})(window,document,'script','dataLayer','GTM-KVCPZSV');"}}]}</script></body></html>